How to save money on medication
The 5 pillars of longevity: Movement, nutrition, sleep, stress reduction, and social connection
Newly approved pill cuts LDL cholesterol levels by more than half
C-reactive protein: Should healthy people be tested for it?
Loneliness linked to cognitive decline and early death
PRP injection for knee osteoarthritis: Does it work?
Strength training over decades linked to longer life
Senator's death calls attention to aortic dissection
Taking breaks from sitting to move around may lower cancer risk
GLP-1 weight-loss drugs may lower the need for knee replacement
Sarah Wakeman, MD, FASAM
Contributor
Dr. Sarah Wakeman is the Medical Director for the Mass General Hospital Substance Use Disorder Initiative and an Assistant Professor of Medicine at Harvard Medical School. She is also the Medical Director of the Mass General Hospital Addiction Consult Team and a clinical lead of the Partners Healthcare Substance Use Disorder Initiative. She received her A.B. from Brown University and her M.D. from Brown Medical School. She completed residency training in internal medicine and served as Chief Medical Resident at Mass General Hospital. She is a diplomate of the American Board of Addiction Medicine. She is secretary for the Massachusetts Society of Addiction Medicine and chair of the policy committee. She previously served on Governor Baker’s Opioid Addiction Working Group.
Clinically she provides specialty addiction and general medical care in the inpatient and outpatient setting at Mass General Hospital and the Mass General Charlestown Health Center. Her active research projects include a study evaluating the impact of addiction consultation on hospitalized medical patients with substance use disorder; a qualitative study exploring the role of recovery coaches for patients with substance use disorder; the healthcare cost and utilization impact of increased addiction treatment services across a health system; and the impact of a hospital-wide substance use disorder initiative on physician attitudes, preparedness, and clinical practice related to substance use disorder.
Posts by Sarah Wakeman, MD, FASAM
Sarah Wakeman, MD, FASAM
Lofexidine: Another option for withdrawal from opioids, but is it better?
Sarah Wakeman, MD, FASAM
Saving lives by prescribing naloxone with opioid painkillers
Sarah Wakeman, MD, FASAM
Fentanyl: The dangers of this potent “man-made” opioid
How to save money on medication
The 5 pillars of longevity: Movement, nutrition, sleep, stress reduction, and social connection
Newly approved pill cuts LDL cholesterol levels by more than half
C-reactive protein: Should healthy people be tested for it?
Loneliness linked to cognitive decline and early death
PRP injection for knee osteoarthritis: Does it work?
Strength training over decades linked to longer life
Senator's death calls attention to aortic dissection
Taking breaks from sitting to move around may lower cancer risk
GLP-1 weight-loss drugs may lower the need for knee replacement